PVP Ventures Acquires 52% Stake in Medilabs to Expand Healthcare Reach
ECONOMY & POLICY

PVP Ventures Acquires 52% Stake in Medilabs to Expand Healthcare Reach

PVP Ventures Limited (PVP) has announced the acquisition of a 52% stake in Biohygea Global Private Limited, known under the brand name Medilabs, marking a significant milestone in its ambition to build a comprehensive global healthcare services platform. This move aligns with PVP’s previously outlined strategy focusing on illness, wellness, and care, with a special emphasis on underserved markets.

The acquisition includes both primary and secondary stake purchases, securing PVP an initial 52% shareholding. PVP also plans to increase its stake over time through additional tranches. Established in 2014 by Dr Prakash, a radiologist, and G Dillibabu, a hospital and lab operations expert, Medilabs operates diagnostic centres and collaborates with local hospitals to set up labs within their premises. It offers a wide test menu of over 1,500 tests and includes facilities such as CT imaging and ultrasound services.

With this partnership, Medilabs will now focus on strengthening its position in Tier 2 and Tier 3 cities, positioning itself as a differentiated diagnostics player in the areas of fetal medicine, genomics, and oncology testing.

Arjun Ananth, CEO of PVP Ventures, commented, “This transaction fills a critical service offering in our strategy of building a powerful house of brands in healthcare services focused on Tier 2 and Tier 3 markets. We welcome Medilab into the PVP fold and look forward to making them a differentiated and scaled diagnostics player in the near future.”

PVP Ventures Limited (PVP) has announced the acquisition of a 52% stake in Biohygea Global Private Limited, known under the brand name Medilabs, marking a significant milestone in its ambition to build a comprehensive global healthcare services platform. This move aligns with PVP’s previously outlined strategy focusing on illness, wellness, and care, with a special emphasis on underserved markets. The acquisition includes both primary and secondary stake purchases, securing PVP an initial 52% shareholding. PVP also plans to increase its stake over time through additional tranches. Established in 2014 by Dr Prakash, a radiologist, and G Dillibabu, a hospital and lab operations expert, Medilabs operates diagnostic centres and collaborates with local hospitals to set up labs within their premises. It offers a wide test menu of over 1,500 tests and includes facilities such as CT imaging and ultrasound services. With this partnership, Medilabs will now focus on strengthening its position in Tier 2 and Tier 3 cities, positioning itself as a differentiated diagnostics player in the areas of fetal medicine, genomics, and oncology testing. Arjun Ananth, CEO of PVP Ventures, commented, “This transaction fills a critical service offering in our strategy of building a powerful house of brands in healthcare services focused on Tier 2 and Tier 3 markets. We welcome Medilab into the PVP fold and look forward to making them a differentiated and scaled diagnostics player in the near future.”

Next Story
Infrastructure Urban

Reliance, Diehl Advance Pact for Precision-Guided Munitions

Diehl Defence CEO Helmut Rauch and Reliance Group’s Founder Chairman Anil D. Ambani have held discussions to advance their ongoing strategic partnership focused on Guided and Terminally Guided Munitions (TGM), under a cooperation agreement originally signed in 2019.This collaboration underscores Diehl Defence’s long-term commitment to the Indian market and its support for the Indian Government’s Make in India initiative. The partnership’s current emphasis is on the urgent supply of the Vulcano 155mm Precision Guided Munition system to the Indian Armed Forces.Simultaneously, the “Vulc..

Next Story
Infrastructure Urban

Modis Navnirman to Migrate to Main Board, Merge Subsidiary

Modis Navnirman Limited has announced that its Board of Directors has approved a key strategic initiative involving migration from the BSE SME platform to the Main Board of both BSE and NSE, alongside a merger with its wholly owned subsidiary, Shree Modis Navnirman Private Limited.The move to the main boards marks a major milestone in the company’s growth trajectory, reflecting its consistent financial performance, robust corporate governance, and long-term commitment to value creation. This transition will grant the company access to a broader investor base, improve market participation, en..

Next Story
Infrastructure Urban

Global Capital Flows Remain Subdued, EMEA Leads in Q1 2025

The Bharat InvITs Association’s industry update for Q1 2025 shows subdued global capital flows, with investment volumes remaining at the lower end of the five-year range despite a late 2024 recovery. According to data from Colliers and MSCI Real Capital Analytics, activity in North America declined slightly, while EMEA maintained steady levels and emerged as the top region for investment in standing assets.The EMEA region now hosts seven of the top ten cross-border capital destinations for standing assets, pushing the United States’ share of global activity below 15 per cent. Meanwhile, in..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?